349 related articles for article (PubMed ID: 30600480)
1. Immunological cure of HBV infection.
Lang J; Neumann-Haefelin C; Thimme R
Hepatol Int; 2019 Mar; 13(2):113-124. PubMed ID: 30600480
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy and therapeutic vaccines for chronic HBV infection.
Lang-Meli J; Neumann-Haefelin C; Thimme R
Curr Opin Virol; 2021 Dec; 51():149-157. PubMed ID: 34710645
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis B virus: from immunobiology to immunotherapy.
Grimm D; Heeg M; Thimme R
Clin Sci (Lond); 2013 Jan; 124(2):77-85. PubMed ID: 23013042
[TBL] [Abstract][Full Text] [Related]
4. Advances in Targeting the Innate and Adaptive Immune Systems to Cure Chronic Hepatitis B Virus Infection.
Meng Z; Chen Y; Lu M
Front Immunol; 2019; 10():3127. PubMed ID: 32117201
[TBL] [Abstract][Full Text] [Related]
5. Heterogeneity of HBV-Specific CD8
Heim K; Neumann-Haefelin C; Thimme R; Hofmann M
Front Immunol; 2019; 10():2240. PubMed ID: 31620140
[TBL] [Abstract][Full Text] [Related]
6. Advances in therapeutics for chronic hepatitis B.
Yang N; Bertoletti A
Hepatol Int; 2016 Mar; 10(2):277-85. PubMed ID: 26363922
[TBL] [Abstract][Full Text] [Related]
7. Toward Curative Immunomodulation Strategies for Chronic Hepatitis B Virus Infection.
Zhu W; Liu H; Zhang X
ACS Infect Dis; 2019 May; 5(5):703-712. PubMed ID: 30907080
[TBL] [Abstract][Full Text] [Related]
8. Circumventing failed antiviral immunity in chronic hepatitis B virus infection: triggering virus-specific or innate-like T cell response?
Koh S; Bertoletti A
Med Microbiol Immunol; 2015 Feb; 204(1):87-94. PubMed ID: 25511870
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-35 Suppresses Antiviral Immune Response in Chronic Hepatitis B Virus Infection.
Shao X; Ma J; Jia S; Yang L; Wang W; Jin Z
Front Cell Infect Microbiol; 2017; 7():472. PubMed ID: 29181338
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B virus-specific CD4 T cell responses differentiate functional cure from chronic surface antigen
Hoogeveen RC; Dijkstra S; Bartsch LM; Drescher HK; Aneja J; Robidoux MP; Cheney JA; Timm J; Gehring A; de Sousa PSF; Ximenez L; Peliganga LB; Pitts A; Evans FB; Boonstra A; Kim AY; Lewis-Ximenez LL; Lauer GM
J Hepatol; 2022 Nov; 77(5):1276-1286. PubMed ID: 35716846
[TBL] [Abstract][Full Text] [Related]
11. Checkpoint Inhibitors and Therapeutic Vaccines for the Treatment of Chronic HBV Infection.
Hoogeveen RC; Boonstra A
Front Immunol; 2020; 11():401. PubMed ID: 32194573
[TBL] [Abstract][Full Text] [Related]
12. Viral hepatitis. HBV cure--can we pin our hopes on immunotherapy?
Yang HC; Kao JH
Nat Rev Gastroenterol Hepatol; 2015 Mar; 12(3):129-31. PubMed ID: 25623202
[TBL] [Abstract][Full Text] [Related]
13. Contribution of Toll-like receptors to the control of hepatitis B virus infection by initiating antiviral innate responses and promoting specific adaptive immune responses.
Ma Z; Zhang E; Yang D; Lu M
Cell Mol Immunol; 2015 May; 12(3):273-82. PubMed ID: 25418467
[TBL] [Abstract][Full Text] [Related]
14. Discrepant Clinical Significance of CD28
Shen XH; Xu P; Yu X; Song HF; Chen H; Zhang XG; Wu MY; Wang XF
Viral Immunol; 2018 Oct; 31(8):548-558. PubMed ID: 30117787
[TBL] [Abstract][Full Text] [Related]
15. Resolution of chronic hepatitis B and anti-HBs seroconversion in humans by adoptive transfer of immunity to hepatitis B core antigen.
Lau GK; Suri D; Liang R; Rigopoulou EI; Thomas MG; Mullerova I; Nanji A; Yuen ST; Williams R; Naoumov NV
Gastroenterology; 2002 Mar; 122(3):614-24. PubMed ID: 11874993
[TBL] [Abstract][Full Text] [Related]
16. Adaptive response in hepatitis B virus infection.
Loggi E; Gamal N; Bihl F; Bernardi M; Andreone P
J Viral Hepat; 2014 May; 21(5):305-13. PubMed ID: 24674098
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B virus-specific T-cell responses during IFN administration in a small cohort of chronic hepatitis B patients under nucleos(t)ide analogue treatment.
Sprinzl MF; Russo C; Kittner J; Allgayer S; Grambihler A; Bartsch B; Weinmann A; Galle PR; Schuchmann M; Protzer U; Bauer T
J Viral Hepat; 2014; 21(9):633-41. PubMed ID: 24251783
[TBL] [Abstract][Full Text] [Related]
18. Antibody-mediated immunotherapy against chronic hepatitis B virus infection.
Gao Y; Zhang TY; Yuan Q; Xia NS
Hum Vaccin Immunother; 2017 Aug; 13(8):1768-1773. PubMed ID: 28521640
[TBL] [Abstract][Full Text] [Related]
19. Immunotherapeutic interventions in chronic hepatitis B virus infection: a review.
Wang L; Zou ZQ; Liu CX; Liu XZ
J Immunol Methods; 2014 May; 407():1-8. PubMed ID: 24747918
[TBL] [Abstract][Full Text] [Related]
20. Immunotherapy for Chronic Hepatitis B Virus Infection.
Bertoletti A; Le Bert N
Gut Liver; 2018 Sep; 12(5):497-507. PubMed ID: 29316747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]